Clinical Trial Update: Adjunctive Pregnenolone in Post-Traumatic Stress Disorder (PTSD) and Depression in Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adjunctive pregnenolone for PTSD and major depressive disorder in OEF/OIF veterans has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Post-traumatic Stress Disorder

Drugs mentioned

• Pregnenolone (pregnenolone)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Post-traumatic Stress Disorder, Major Depressive Disorder | Phase 2 | Status: WITHDRAWN